Invest in a Scalable Royalty Business Model in U.S. Cannabis

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company focused on California, the largest Cannabis market in North America, that provides growth capital to emerging private companies in the licensed U.S. cannabis industry.

Discover how FinCanna Capital's scalable royalty-based business model delivers high-impact returns to shareholders by downloading the investor presentation:

Why Invest in FinCanna?

Innovative Model

Growing Portfolio

Access a strategically-diversified investment portfolio of high-growth emerging cannabis companies.

Royalty-based business model provides an alternative for businesses and scale to shareholders.

FinCanna has three active investments that target various parts of the cannabis industry.

Experienced Team

Near-term Growth

Led by highly-seasoned executives and advisors with expertise in capital markets, cannabis law and the California cannabis industry.

Management expects a sizable increase in royalties in 2021 with positive industry tailwinds.

FinCanna’s Royalty Portfolio Investee Companies

QVI Inc.

QVI Inc. is a cannabis infused product manufacturer located in Sonoma, California. Doing business as "The Galley", it has a fully licensed 8,300 sq. ft. facility that is focused on high demand areas of production, including edibles, topicals, tinctures, chocolates, hard candies, gummies, beverages and other products.

Cultivation Technologies Inc.

Cultivation Technologies Inc. is a multi-award winning extraction and manufacturing enterprise located in Palm Desert, CA that provides high-quality Butane hash oil concentrates for white label manufacturing, toll processing and packaging to hand-selected brands.

ezGreen Compliance

ezGreen Compliance is a state-of-the-art enterprise compliance and point of sale software solution for licensed medical cannabis dispensaries and cultivators. It's the only HIPAA certified point of sale software in the market.

Download the Investor Presentation & Receive Updates

For FinCanna's cautionary note regarding forward-looking information visit:

Copyright © 2021. All rights reserved.